CAS 175481-37-5
:(2S)-2-(Acetylamino)-3-methoxy-N-(phenylmethyl)propanamide
- (S)-2-Acetamido-N-benzyl-3-methoxypropanamide
- (2S)-2-(Acetylamino)-3-methoxy-N-(phenylmethyl)propanamide
- Propanamide, 2-(acetylamino)-3-methoxy-N-(phenylmethyl)-, (S)-
- SPM 6953
- Propanamide, 2-(acetylamino)-3-methoxy-N-(phenylmethyl)-, (2S)-
Lacosamide S-Enantiomer ((S)-2-(Acetylamino)-N-benzyl-3-methoxypropanamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C13H18N2O3Color and Shape:White PowderMolecular weight:250.13174Lacosamide EP Impurity A ((S)-Lacosamide)
CAS:Formula:C13H18N2O3Color and Shape:White To Off-White SolidMolecular weight:250.30Epi-Lacosamide
CAS:Applications Epi-Lacosamide is an impurity of Lacosamide (L098500), a medication used for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain. Lacosamide is a potent anticonvulsant.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Choi, D., et al.: J. Med. Chem., 39, 1907 (1996), Morieux, P., et al.: Bioorg. Med. Chem., 16, 8968 (2008),Formula:C13H18N2O3Color and Shape:WhiteMolecular weight:250.29(S)-2-Acetamido-N-benzyl-3-methoxypropanamide
CAS:Controlled ProductLacosamide is a drug that is used to treat epilepsy and other neurological disorders. It acts as an inhibitor of voltage-gated sodium channels, which are proteins that regulate the passage of sodium ions through the cell membrane. Lacosamide has been shown to be effective in a number of clinical trials for stroke, Parkinson's disease, and Alzheimer's disease. This drug also has potential use in treating women with depression, based on its ability to inhibit serotonin reuptake and increase serotonin transmission. Lacosamide has been shown to be safe and well tolerated in clinical trials involving humans. There are no reports of serious side effects or deaths related to this drug.
Formula:C13H18N2O3Purity:Min. 95%Molecular weight:250.29 g/mol






